For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Verinata Health, Inc.

USPTO Granted Patents = 55

CIPO Patents = 48

EPO Patents = 39

Trademarks = 2

Forward Citations = 1,055

Loading Chart...

Loading Chart...

51 inventors (with patents filed for the assignee):

Richard P Rava (36 out of 82 patents)

Mehmet Toner (15 out of 99 patents)

Ravi Kapur (15 out of 50 patents)

4. Brian K Rhees (15 out of 16 patents)

5. David A Comstock (12 out of 12 patents)

6. Roland B Stoughton (12 out of 13 patents)

7. Daniel D Shoemaker (10 out of 26 patents)

8. Ronald W Davis (9 out of 62 patents)

9. Manjula Chinnappa (8 out of 8 patents)

10. Gabrielle Heilek (8 out of 8 patents)

11. Darya Chudova (6 out of 48 patents)

12. John P Burke (6 out of 10 patents)

13. Yue-Jen Chuu (6 out of 6 patents)

14. Anupama Srinivasan (5 out of 8 patents)

15. Barb Ariel Cohen (4 out of 11 patents)

Core Competencies:

Genomic DNA

Chromosomal Aneuploidies

Fetal Nucleic Acids

Copy Number Variation

Cell-Free DNA

Fetal Abnormalities

Polymorphic Sequences

Prenatal Diagnoses

Cancer Detection

Sample Splitting

DNA Tags

Sequencing Methods

55 patents: Sort by Forward Citations

1. 12435373 - Identification of polymorphic sequences in mixtures of genomic DNA (2025-10-07),

2. 12367947 - Normalizing chromosomes for the determination and verification of common and rare chromosomal aneuploidies (2025-07-22),

3. 12217827 - Detecting fetal sub-chromosomal aneuploidies (2025-02-04),

4. 12139760 - Methods for determining fraction of fetal nucleic acids in maternal samples (2024-11-12),

5. 11952623 - Simultaneous determination of aneuploidy and fetal fraction (2024-04-09),

6. 11884975 - Sequencing methods and compositions for prenatal diagnoses (2024-01-30),

7. 11875899 - Analyzing copy number variation in the detection of cancer (2024-01-16),

8. 11781187 - Rare cell analysis using sample splitting and DNA tags (2023-10-10),

9. 11697846 - Detecting and classifying copy number variation (2023-07-11),

10. 11674176 - Fetal aneuploidy detection by sequencing (2023-06-13),

11. 11430541 - Using cell-free DNA fragment size to determine copy number variations (2022-08-30),

12. 11378498 - Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats (2022-07-05),

13. 11335437 - Set membership testers for aligning nucleic acid samples (2022-05-17),

14. 11332774 - Method for determining copy number variations (2022-05-17),

15. 11286520 - Method for determining copy number variations (2022-03-29),

Verinata Health, Inc. is a leading genomic diagnostics company that specializes in non-invasive prenatal testing (NIPT) technology. They provide advanced genetic screening services for pregnant women to detect chromosomal abnormalities in the fetus with high accuracy. Verinata Health's innovative Verifi test offers a safe, early, and reliable option for prenatal screening, helping healthcare providers make informed decisions for their patients. With a focus on improving patient care, Verinata Health is dedicated to advancing the field of prenatal genetics through cutting-edge genetic technologies and research.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

55 Patents

#32 in Redwood City, CA

#1,468 in California

#6,231 in US

#12,527 in the World

Redwood City, CA, United States of America

Verinata Health, Inc.

Forward Citations = 1,055

51 inventors:

Richard P Rava (36 out of 82 patents)

Mehmet Toner (15 out of 99 patents)

Ravi Kapur (15 out of 50 patents)

4. Brian K Rhees (15 out of 16 patents)

5. David A Comstock (12 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…